Vor Bio Announces $55.6 Million Private Placement
Intend to announce updated clinical data from Phase 1/2 VBP301 trial of…
Epitopea and Genevant Sciences Announce Collaboration Agreement
December 19, 2024 16:30 ET | Source: Genevant Sciences CAMBRIDGE, United Kingdom…
Nxera Pharma and Shionogi Launch QUVIVIQ in Japan for Adults with Insomnia
December 18, 2024 21:35 ET | Source: Nxera Pharma Tokyo, Japan and…
NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024
Participants can register here for the virtual event airing 9:00am ET /…
ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration
LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 11, 2024 (GLOBE NEWSWIRE) -- ProQR…
2024 PHBS-CJBS Global Pitch Competition Grand Final Held
SHENZHEN, China, Dec. 11, 2024 /PRNewswire/ -- The 2024 PHBS-CJBS Global Pitch Competition,…
Merus Announces FDA Approval of BIZENGRI (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ NonSmall Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study
BIZENGRI® is the first and only therapy approved by the FDA specifically…
Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024
– Petosemtamab 1500 mg monotherapy phase 2 interim data continues to demonstrate…
Immuneering to Present at the Piper Sandler 36 Annual Healthcare Conference
CAMBRIDGE, Mass., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…
Bionomics Provides an Update on Re-domiciliation via Scheme of Arrangement
November 08, 2024 16:15 ET | Source: Bionomics Ltd ADELAIDE, Australia and CAMBRIDGE,…